Only a few months after Medtronic completed its acquisition of cardiac device maker Affera, the nearly billion-dollar buyout is already paying off. A dual-use catheter originally developed by Affera ...
First-of-its-kind, all-in-one HD-mapping and dual energy (pulsed field and radiofrequency) ablation catheter Highly anticipated by electrophysiologists for its innovation and demonstrated safety and ...
(RTTNews) - Boston Scientific Corp. (BSX) said it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal ...
The EnSite Precision cardiac mapping system was developed to be used seamlessly with the existing portfolio of St. Jude Medical™ EP products, including the TactiCath Quartz Ablation Catheter System, ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved a mapping and dual-energy catheter ablation system for treatment of persistent AF. The system ...
Medtronic kicked off the week with news that it plans to strengthen its cardiac ablation buiness with the acquisition of Affera for an undisclosed sum. The deal also provides Medtronic with an entry ...
Abbott has received an FDA clearance for the latest version of its sensor-laden catheter used to map out the electrical activity of the heart muscle—a device the company says will help support its ...
SAN DIEGO--(BUSINESS WIRE)--Vektor Medical, Inc. today announced the University of California, San Diego Health (UCSD) as the first hospital system in the world to offer its recently U.S. Food and ...
There is an indisputable trend toward minimally invasive, outpatient procedures in healthcare. Outpatient procedures help to alleviate burdens on the healthcare system, save patients time, money, and ...
The heart is at the center of a complex electrical system. Just like any machine, sometimes the system does not always work correctly. There may be a short circuit. This could lead to an abnormal or ...
Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announces the launch of CARTO™ 3 System Version 8, the latest version of the company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results